Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.
about
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel diseaseUstekinumab in treatment of Crohn's disease: design, development, and potential place in therapySystematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseasesIndicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United StatesMaking sense of the cause of Crohn's - a new look at an old disease.Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease.Use of anti-TNF drug levels to optimise patient management.Top-down approach to biological therapy of Crohn's disease.Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.Next-Generation Therapeutics for Inflammatory Bowel Disease.Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications.The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease.Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.Dietary Therapy with the Crohn's Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy.The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.Can We Predict the Efficacy of Anti-TNF-α Agents?Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature.The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn's disease.Optimization of biologic therapy in Crohn's disease.Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort.Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease.Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.Old and New Lymphocyte Players in Inflammatory Bowel Disease.Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure.Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease.Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis.Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.Early change in faecal calprotectin predicts primary non-response to anti-TNFα therapy in Crohn's disease.Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease.A New Venue of TNF Targeting.Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
P2860
Q26745721-F66E66BD-D680-4DD5-A0A4-28F3D1A55178Q28067631-A50BCC27-AB9E-4AC7-BA0D-9004B5B939CEQ28072105-8F803233-F67A-4F6C-A464-41102A0FD982Q33584629-DDC80736-C823-48C0-AC54-A57235F37EAFQ37577712-0E811B37-4184-4524-878F-753E150686F1Q37672250-3E3AAA2E-6446-4B39-AEF4-0BB2B3EAA2EEQ38608951-BF0001EE-DDFC-479D-A3D7-98316EB10997Q38764671-B3116313-8F2D-458D-AFF7-085873B44638Q38805575-9B7EA834-FA7C-44E5-9CB2-AFE4C403613CQ38909523-AC0DB74C-B580-43EF-996E-FC2124E4B891Q38979811-A4DA37A1-9DEF-4D42-8863-0DC76F626DC3Q39018436-3842A2F9-72A8-4640-AE82-E86B01C4D831Q39030608-0455F975-6682-49FA-856D-6DD95A581102Q39084748-3A2F743F-397C-46F0-A6F7-3452BAFF3FD7Q40194284-DD6E943A-A061-439C-8797-21B295124064Q40703329-3576E11C-A539-48C6-AF97-8D4EFDAB30A1Q41660559-E15608C1-E2E3-4446-A525-CCBB95DD0D06Q42343328-36B5CAF4-0466-4EA4-8750-066C5FA37C6BQ47109861-032D1CFE-A003-4AB3-8A30-52F9F8C5FFF2Q47142918-7331340C-E70D-41B0-AC42-4B4758419CE1Q47389870-05AE2D66-8542-4786-A9D1-9BBCAFCBFA26Q47805665-24E180AC-DD97-4CB1-8299-410D07211892Q48021336-D22071CE-B91B-42AC-B46D-B5623F507492Q48144954-ADEED3D4-1837-4AE6-94BC-D2CA7E11F2C8Q48172992-42CCC7F2-BA1C-44DE-AE58-CC610B19485DQ48192590-4F34E949-2BCE-442A-A688-5681BCB6D89AQ48327816-063E36AC-C467-4949-99A9-21E2073B88A1Q48351328-B0051BE2-1E9D-4B29-A1E8-E45334FC3734Q49101989-D7FB2AB2-735E-43F9-AC00-71B5FE6D3795Q49537996-F28B4A40-C939-4A0F-9E8D-3F066087C8C6Q50879154-41FDAC51-19B1-4492-B9CA-AFA715401203Q51584215-7B46CE26-1AAA-426A-9857-35235AD97BD3Q51649850-53328267-CDC2-4EEF-8848-E4B0AAABA576Q53243386-50AE18FD-202C-4634-A3B8-9714F6B1D7C5Q55001725-160B0A57-2B7B-4481-9AFB-604F7E2AA657Q57067878-84BA9F28-95F9-4349-817F-A8DB9C8390A5
P2860
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Systematic review: predicting ...... ithm for practical management.
@en
type
label
Systematic review: predicting ...... ithm for practical management.
@en
prefLabel
Systematic review: predicting ...... ithm for practical management.
@en
P2860
P356
P1476
Systematic review: predicting ...... rithm for practical management
@en
P2093
P2860
P356
10.1111/APT.13445
P407
P50
P577
2015-10-30T00:00:00Z